The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
The global Angina market was valued at US$ 10400 million in 2023 and is anticipated to reach US$ 14180 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Angina, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angina.
Report Scope
The Angina market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angina market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angina companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Segment by Type
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine
Segment by Application
Clinics
Hospitals
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angina companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
The global Angina market was valued at US$ 10400 million in 2023 and is anticipated to reach US$ 14180 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Angina, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angina.
Report Scope
The Angina market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angina market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angina companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Segment by Type
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine
Segment by Application
Clinics
Hospitals
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angina companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angina Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Beta Blockers
1.2.3 Calcium Antagonists
1.2.4 Anticoagulants
1.2.5 Antiplatelet
1.2.6 Nitrates
1.2.7 ACE Inhibitors
1.2.8 Ranolazine
1.3 Market by Application
1.3.1 Global Angina Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angina Market Perspective (2019-2030)
2.2 Angina Growth Trends by Region
2.2.1 Global Angina Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Angina Historic Market Size by Region (2019-2024)
2.2.3 Angina Forecasted Market Size by Region (2025-2030)
2.3 Angina Market Dynamics
2.3.1 Angina Industry Trends
2.3.2 Angina Market Drivers
2.3.3 Angina Market Challenges
2.3.4 Angina Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angina Players by Revenue
3.1.1 Global Top Angina Players by Revenue (2019-2024)
3.1.2 Global Angina Revenue Market Share by Players (2019-2024)
3.2 Global Angina Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Angina Revenue
3.4 Global Angina Market Concentration Ratio
3.4.1 Global Angina Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angina Revenue in 2023
3.5 Angina Key Players Head office and Area Served
3.6 Key Players Angina Product Solution and Service
3.7 Date of Enter into Angina Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Angina Breakdown Data by Type
4.1 Global Angina Historic Market Size by Type (2019-2024)
4.2 Global Angina Forecasted Market Size by Type (2025-2030)
5 Angina Breakdown Data by Application
5.1 Global Angina Historic Market Size by Application (2019-2024)
5.2 Global Angina Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Angina Market Size (2019-2030)
6.2 North America Angina Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Angina Market Size by Country (2019-2024)
6.4 North America Angina Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angina Market Size (2019-2030)
7.2 Europe Angina Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Angina Market Size by Country (2019-2024)
7.4 Europe Angina Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angina Market Size (2019-2030)
8.2 Asia-Pacific Angina Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Angina Market Size by Region (2019-2024)
8.4 Asia-Pacific Angina Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angina Market Size (2019-2030)
9.2 Latin America Angina Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Angina Market Size by Country (2019-2024)
9.4 Latin America Angina Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angina Market Size (2019-2030)
10.2 Middle East & Africa Angina Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Angina Market Size by Country (2019-2024)
10.4 Middle East & Africa Angina Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Angina Introduction
11.1.4 Amgen Revenue in Angina Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Taxus Cardium Pharmaceuticals
11.2.1 Taxus Cardium Pharmaceuticals Company Detail
11.2.2 Taxus Cardium Pharmaceuticals Business Overview
11.2.3 Taxus Cardium Pharmaceuticals Angina Introduction
11.2.4 Taxus Cardium Pharmaceuticals Revenue in Angina Business (2019-2024)
11.2.5 Taxus Cardium Pharmaceuticals Recent Development
11.3 LegoChem Biosciences
11.3.1 LegoChem Biosciences Company Detail
11.3.2 LegoChem Biosciences Business Overview
11.3.3 LegoChem Biosciences Angina Introduction
11.3.4 LegoChem Biosciences Revenue in Angina Business (2019-2024)
11.3.5 LegoChem Biosciences Recent Development
11.4 Lee’s Pharmaceutical
11.4.1 Lee’s Pharmaceutical Company Detail
11.4.2 Lee’s Pharmaceutical Business Overview
11.4.3 Lee’s Pharmaceutical Angina Introduction
11.4.4 Lee’s Pharmaceutical Revenue in Angina Business (2019-2024)
11.4.5 Lee’s Pharmaceutical Recent Development
11.5 Milestone Pharmaceuticals
11.5.1 Milestone Pharmaceuticals Company Detail
11.5.2 Milestone Pharmaceuticals Business Overview
11.5.3 Milestone Pharmaceuticals Angina Introduction
11.5.4 Milestone Pharmaceuticals Revenue in Angina Business (2019-2024)
11.5.5 Milestone Pharmaceuticals Recent Development
11.6 Juventas Therapeutics
11.6.1 Juventas Therapeutics Company Detail
11.6.2 Juventas Therapeutics Business Overview
11.6.3 Juventas Therapeutics Angina Introduction
11.6.4 Juventas Therapeutics Revenue in Angina Business (2019-2024)
11.6.5 Juventas Therapeutics Recent Development
11.7 ViroMed
11.7.1 ViroMed Company Detail
11.7.2 ViroMed Business Overview
11.7.3 ViroMed Angina Introduction
11.7.4 ViroMed Revenue in Angina Business (2019-2024)
11.7.5 ViroMed Recent Development
11.8 Kuhnil Pharmaceutical
11.8.1 Kuhnil Pharmaceutical Company Detail
11.8.2 Kuhnil Pharmaceutical Business Overview
11.8.3 Kuhnil Pharmaceutical Angina Introduction
11.8.4 Kuhnil Pharmaceutical Revenue in Angina Business (2019-2024)
11.8.5 Kuhnil Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
